125 related articles for article (PubMed ID: 20138721)
1. Diagnostic utility of DTI in prostate cancer.
Gürses B; Tasdelen N; Yencilek F; Kılıckesmez NO; Alp T; Fırat Z; Albayrak MS; Uluğ AM; Gürmen AN
Eur J Radiol; 2011 Aug; 79(2):172-6. PubMed ID: 20138721
[TBL] [Abstract][Full Text] [Related]
2. Diffusion tensor imaging of prostate at 3.0 Tesla.
Li C; Chen M; Li S; Zhao X; Zhang C; Liu M; Zhou C
Acta Radiol; 2011 Sep; 52(7):813-7. PubMed ID: 21586608
[TBL] [Abstract][Full Text] [Related]
3. Diffusion tensor magnetic resonance imaging of prostate cancer.
Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.
Nagel KN; Schouten MG; Hambrock T; Litjens GJ; Hoeks CM; ten Haken B; Barentsz JO; Fütterer JJ
Radiology; 2013 Apr; 267(1):164-72. PubMed ID: 23329653
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
[TBL] [Abstract][Full Text] [Related]
6. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
[TBL] [Abstract][Full Text] [Related]
7. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
8. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
Kim JH; Kim JK; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-tensor MRI at 3 T: differentiation of central gland prostate cancer from benign prostatic hyperplasia.
Park SY; Kim CK; Park BK; Ha SY; Kwon GY; Kim B
AJR Am J Roentgenol; 2014 Mar; 202(3):W254-62. PubMed ID: 24555622
[TBL] [Abstract][Full Text] [Related]
10. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy.
Takayama Y; Kishimoto R; Hanaoka S; Nonaka H; Kandatsu S; Tsuji H; Tsujii H; Ikehira H; Obata T
J Magn Reson Imaging; 2008 Jun; 27(6):1331-5. PubMed ID: 18504751
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor MRI: preliminary anisotropy measures and mapping of breast tumors.
Partridge SC; Ziadloo A; Murthy R; White SW; Peacock S; Eby PR; DeMartini WB; Lehman CD
J Magn Reson Imaging; 2010 Feb; 31(2):339-47. PubMed ID: 20099346
[TBL] [Abstract][Full Text] [Related]
12. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
Gibbs P; Liney GP; Pickles MD; Zelhof B; Rodrigues G; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):572-6. PubMed ID: 19692841
[TBL] [Abstract][Full Text] [Related]
13. Interscanner comparison of dynamic contrast-enhanced MRI in prostate cancer: 1.5 versus 3 T MRI.
Sertdemir M; Schoenberg SO; Sourbron S; Hausmann D; Heinzelbecker J; Michaely HJ; Dinter DJ; Weidner AM
Invest Radiol; 2013 Feb; 48(2):92-7. PubMed ID: 23249646
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
[TBL] [Abstract][Full Text] [Related]
15. Diffusion changes in patients with systemic lupus erythematosus.
Zhang L; Harrison M; Heier LA; Zimmerman RD; Ravdin L; Lockshin M; Uluğ AM
Magn Reson Imaging; 2007 Apr; 25(3):399-405. PubMed ID: 17371731
[TBL] [Abstract][Full Text] [Related]
16. [Non-granulomatous prostatitis: MRI image with endorectal surface coil ("Endo-MRI")].
Szolar DH; Ranner G; Preidler KW; Lax S
Aktuelle Radiol; 1995 Jan; 5(1):67-9. PubMed ID: 7888435
[TBL] [Abstract][Full Text] [Related]
17. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
18. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results.
Quentin M; Pentang G; Schimmöller L; Kott O; Müller-Lutz A; Blondin D; Arsov C; Hiester A; Rabenalt R; Wittsack HJ
Magn Reson Imaging; 2014 Sep; 32(7):880-5. PubMed ID: 24848289
[TBL] [Abstract][Full Text] [Related]
20. [PI-RADS classification: structured reporting for MRI of the prostate].
Röthke M; Blondin D; Schlemmer HP; Franiel T
Rofo; 2013 Mar; 185(3):253-61. PubMed ID: 23404430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
